Wilson S E, Boswick J A, Duma R J, Echols R M, Jemsek J G, Lerner R, Lewis R T, Najem A Z, Press R A, Rittenbury M S
Department of Surgery, Harbor-UCLA Medical Center, Torrance.
Am J Surg. 1988 May 31;155(5A):61-6. doi: 10.1016/s0002-9610(88)80215-0.
Three broad-spectrum cephalosporins (cefotetan, moxalactam, and cefoxitin) proved effective in this randomized, prospective trial for treatment of 303 surgical patients with moderately severe regional peritonitis.